虚拟生物技术:用于治疗发现和开发的多代理人工智能框架
bioRxiv : the preprint server for biology
|March 11, 2026
概括
一个新的AI团队,虚拟生物技术,通过整合各种数据和专业知识来加速药物发现. 这种方法增强了目标识别和治疗开发,提高了成功率并减少了不良事件.
科学领域:
- 在药物发现中计算生物学和人工智能.
- 治疗开发的多原子数据集成.
背景情况:
- 药物发现面临的挑战是整合跨生物尺度的碎片化数据,工具和专业知识.
- 当前的方法往往难以对各种证据进行全面的分析.
研究的目的:
- 介绍虚拟生物技术,一个人工智能代理团队,旨在进行端到端的计算药物发现.
- 展示虚拟生物技术在分析临床试验数据和评估药物标方面的能力.
主要方法:
- 开发一个首席科学官代理人,将任务委托给专门的科学家代理人.
- 利用各种数据来源,包括统计遗传学,基因组学,途径,化学信息学和临床数据.
- 虚拟生物技术的应用,以分析临床试验结果,评估癌症标,并调查试验失败.
主要成果:
- 人工智能代理人分析了55984项临床试验,确定了与药物向成功相关的基因组特征.
- 针对细胞类型特定基因的药物显示出明显更高的进展率 (I至II期:40%,IV期:48%) 和较少的不良事件 (32%).
- 虚拟生物技术成功评估了B7-H3的肺癌,并为终止的性结肠炎试验提出了战略.
结论:
- 虚拟生物技术可以实现透明,高效和全面的多尺度治疗分析.
- 这种人工智能驱动的方法加速了早期药物发现工作流程.
- 该系统让人类科学家参与其中,同时提高计算能力.
相关概念视频
Microorganisms in Medicine and Therapeutics
1.3K
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
1.3K
Drug Discovery: Overview
12.6K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.6K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
Synthetic Biology
5.7K
Synthetic biology is an interdisciplinary science that involves using principles from disciplines such as engineering, molecular biology, cell biology, and systems biology. It involves remodeling existing organisms from nature or constructing completely new synthetic organisms for applications such as protein or enzyme production, bioremediation, value-added macromolecule production, and the addition of desirable traits to crops, to name a few.
Golden rice
Golden rice is a genetically modified...
Golden rice
Golden rice is a genetically modified...
5.7K
Preclinical Development: Overview
6.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
6.3K
Therapeutic Index
7.3K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
7.3K


